Skip to content

OpenRx Open Medications Explorer

Browse Drugs Ingredients Biologics Veterinary Safety Reports AI Co-Pilot

Browse Filter by letter, class, form, route or application type
Drugs The complete A–Z catalogue
Ingredients Monographs grouped by active ingredient
Biologics Licensed biological products
Veterinary Approved animal drugs and adverse events
Safety Recalls, shortages and post-market signals
Reports Independent research reports and their sources
AI Co-Pilot Regulatory Q&A, MedDRA/VeDDRA coding and openFDA query help
About & data sources

© 2026 OpenRx · public-domain U.S. government data

This resource is provided to you free, as a public benefit.

It does not serve as medical advice, and by using this site you explicitly forfeit your right to sue, hold liable, or in any way blame, Jon "Mike" Schlottig, Leverage AI LLC, and any and all partners and subsidiaries, past present and future, as it relates to information and subsequent decisions made as a result of using this informational resource. Read the full disclaimer

I built this site and unified these databases because I hate when companies obscure valuable and potentially life saving information like this, and thought: "I'm actually fully capable of changing this with a minimal amount of time and effort, I should probably quit complaining and just do it." — Jon "Mike" Schlottig

Leverage AI LLC

Home
Browse
Pharmacologic classes
Cytochrome P450 2C8 Inducers

Cytochrome P450 2C8 Inducers

21 medication records in the pharmacologic class “Cytochrome P450 2C8 Inducers [MoA]”.

21 medications

CAVHANZA Nilotinib · Tablet, Orally Disintegrating
Rx NDA 2 NDC
CEREBYX Fosphenytoin Sodium · Injection, Solution
Rx NDA TE AP 3 NDC
DANZITEN nilotinib · Tablet
Rx NDA 2 NDC
DILANTIN Extended Phenytoin Sodium · Capsule, Extended Release
Rx ANDA TE AB 3 NDC
Extended Phenytoin Sodium Phenytoin Sodium · Capsule
Rx ANDA TE AB 3 recalls 5 NDC
Fosphenytoin sodium Injection, Solution
Rx ANDA TE AP 2 recalls 8 NDC
Fosphenytoin Sodium Injection
Rx ANDA TE AP 4 NDC
nilotinib Capsule
Rx ANDA TE AB 2 recalls 21 NDC
ORKAMBI lumacaftor and ivacaftor · Granule
Rx NDA 3 NDC
ORKAMBI lumacaftor and ivacaftor · Tablet, Film Coated
Rx NDA 2 NDC
Phenytek extended phenytoin sodium · Capsule, Extended Release
Rx ANDA TE AB 3 NDC
Phenytoin Suspension
Rx ANDA TE AB 1 recall 5 NDC
Phenytoin Tablet, Chewable
Rx ANDA TE AB 6 NDC
Phenytoin Infatabs Phenytoin · Tablet, Chewable
Rx ANDA TE AB 2 NDC
Phenytoin Sodium Capsule, Extended Release
Rx ANDA TE AB 15 NDC
Phenytoin Sodium Injection
Rx ANDA TE AP 2 recalls 11 NDC
PHENYTOIN SODIUM Phenytoin Sodium · Capsule
Rx ANDA TE AB 2 NDC
PYRUKYND mitapivat · Tablet, Film Coated
Rx NDA 4 NDC
Tafinlar dabrafenib · Capsule
Rx NDA 2 NDC
Tasigna nilotinib · Capsule
Rx NDA TE AB 3 NDC
Xcopri cenobamate · Tablet, Film Coated
Rx NDA 5 NDC

OpenRx

A unified explorer for every publicly documented medication, assembled from fourteen open U.S. government datasets.

Data sources & licensing

Powered by Leverage AI LLC

Explore

Browse everything
Complete A–Z index
Active ingredients
Pharmacologic classes
Dosage forms
Routes of administration

Therapeutics

Human prescription
Over-the-counter
Biologics & biosimilars
Veterinary medicines
Recently approved

Safety

Recalls
Drug shortages
Most reported events
Search

About

About OpenRx
Data sources
Methodology
Disclaimer
Build changelog

Reports

Independent reports
FDA & veterinary databases

Not medical advice. OpenRx is an informational index of public regulatory data. It is not a substitute for the professional judgement of a qualified health professional, and it is not the official FDA labelling. Always consult the manufacturer's current prescribing information and your clinician.

© 2026 OpenRx

Full-text search across medication names, ingredients, manufacturers, pharmacologic classes and official prescribing information.

/ or Ctrl+K to open · Esc to close · dedicated search page